Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIM | PSTX | ADAP | ||
| Company | Alimera Sciences Inc | Poseida Therapeutics Inc | Adaptimmune Ther ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.56 | 3.08 | 1.2000 | ||
| High | 5.58 | 3.26 | 1.2700 | ||
| Low | 5.56 | 3.05 | 1.1650 | ||
| Last | 5.58 | 3.23 | 1.2100 | ||
| Change | +0.01 | +0.17 | +0.0400 | ||
| % Change | +0.18% | +5.56% | +3.42% | ||
| Volume | 84,400 | 348,600 | 1,208,000 | ||
| 20-Day Average Volume | 809,275 | 468,750 | 1,708,070 | ||
| Previous Close | 5.57 | 3.06 | 1.1700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.55 | 3.04 | 1.1139 | ||
| 20-Day Raw Stochastic | 50.00% | 67.77% | 70.64% | ||
| 20-Day Relative Strength | 75.82% | 55.66% | 55.97% | ||
| Weighted Alpha | +15.44 | +4.27 | -12.07 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Sell | 40% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 07/15/24 | -5.00% since 07/15/24 | -2.81% since 07/15/24 | ||
| Low | 5.56 on 07/22/24 | 3.01 on 07/19/24 | 1.1300 on 07/19/24 | ||
| High | 5.60 on 07/16/24 | 3.55 on 07/16/24 | 1.3100 on 07/17/24 | ||
| 1-Month | |||||
| %Chg | +77.14% since 06/21/24 | +16.19% since 06/21/24 | +35.96% since 06/21/24 | ||
| Low | 5.51 on 06/26/24 | 2.41 on 06/27/24 | 0.8250 on 06/26/24 | ||
| High | 5.65 on 06/24/24 | 3.62 on 07/12/24 | 1.3700 on 07/15/24 | ||
| 3-Month | |||||
| %Chg | +57.63% since 04/22/24 | +49.88% since 04/22/24 | +19.80% since 04/22/24 | ||
| Low | 2.77 on 06/10/24 | 1.98 on 04/25/24 | 0.8250 on 06/26/24 | ||
| High | 5.65 on 06/24/24 | 3.62 on 07/12/24 | 1.3700 on 07/15/24 | ||
| 6-Month | |||||
| %Chg | +42.71% since 01/22/24 | +7.31% since 01/22/24 | +66.60% since 01/22/24 | ||
| Low | 2.77 on 06/10/24 | 1.87 on 04/16/24 | 0.6905 on 01/25/24 | ||
| High | 5.65 on 06/24/24 | 4.27 on 03/01/24 | 2.0500 on 03/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 291,807 | 296,692 | 288,785 | ||
| Shares Outstanding, K | 52,389 | 96,958 | 246,825 | ||
| Annual Sales | 80,750,000 | 64,700,000 | 60,280,000 | ||
| Annual Net Income | -20,130,000 | -123,430,000 | -113,870,000 | ||
| Last Quarter Sales | 23,010,000 | 28,140,000 | 5,680,000 | ||
| Last Quarter Net Income | -6,250,000 | -24,270,000 | -48,500,000 | ||
| 60-Month Beta | 1.28 | 0.53 | 2.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/14/24 | -0.25 on 05/14/24 | -0.18 on 05/15/24 | ||
| Latest Earnings Date | 08/08/24 | 08/13/24 | 08/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||